Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company is engaged in manufacturing of pharmaceutical and personal care products such as active pharmaceutical ingredients, and formulations in therapeutic areas.
Cipla Health Limited, is an unlisted public company incorporated on 27 August, 2015. It is classified as a public limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 10.00 cr and the total paid-up capital is INR 2.33 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
5.31%
1.69%
2.09%
62.76%
-60.81%
-0.61%
-0.14
-0.44
-0.3
-18.85
-9.36
-0.59
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(44)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Samina Hamied | 00027923 | 6 years |
| Director | Amrita D C Nautiyal | 00123512 | 6 years |
| Director | Umang Vohra | 02296740 | 2 years |
| Director | Geena Malhotra | 03134169 | 1 years |
| Director | Chandrashekhar Ramachandran Iyer | 07173310 | 6 years |
| Director | Achin Gupta | 09491674 | 3 years |
| CEO | Shivam Puri | <HIDDEN> | 6 years |
| Whole-time Director | Shivam Puri | 09552961 | 3 years |
| CS | Siddharth Rajesh Jain | <HIDDEN> | 5 years |
| CFO | Sukh Dev Jaluka | <HIDDEN> | 3 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| HAMSONS LABORATORIES PRIVATE LIMITED |
Converted to LLP and Dissolved
|
40.0 L | 1 | Maharashtra |
| TWIST PHARMA PRIVATE LIMITED |
Strike Off
|
25.0 L | 1 | Maharashtra |
| CIPLA LIMITED |
Active
|
161.5 Cr | 2 | Maharashtra |
| JAY PRECISION PHARMACEUTICALS PRIVATE LIMITED |
Active
|
4.0 Cr | 3 | Maharashtra |
| RELIANCE ASSET RECONSTRUCTION COMPANY LIMITED |
Active
|
100.0 Cr | 1 | Maharashtra |
| GANDHAR OIL REFINERY (INDIA) LIMITED |
Active
|
19.6 Cr | 1 | Maharashtra |
| MATIX FERTILISERS AND CHEMICALS LIMITED |
Active
|
2,215.5 Cr | 1 | West Bengal |
| LITTLE INTERNET PRIVATE LIMITED |
Active
|
22.4 Cr | 1 | Delhi |
| RIVERSIDE INDUSTRIES LIMITED |
Active
|
6.2 Cr | 1 | Maharashtra |
| I-VEN PHARMA CAPITAL LIMITED |
Under Liquidation
|
8.9 L | 1 | Karnataka |
| STEMPEUTICS RESEARCH PRIVATE LIMITED |
Active
|
59.7 Cr | 1 | Karnataka |
| SIGNET EXCIPIENTS PRIVATE LIMITED |
Active
|
1.8 Cr | 1 | Maharashtra |
| CHANDRASHEKHAR IYER & CO LLP |
Active
|
1.0 L | 1 | Maharashtra |
| CIPLA PHARMA AND LIFE SCIENCES LIMITED |
Active
|
258.7 Cr | 1 | Maharashtra |
| ACHIRA LABS PRIVATE LIMITED |
Active
|
9.8 Cr | 1 | Karnataka |
| CIPLA DIGITAL HEALTH LIMITED |
Active
|
30.0 Cr | 1 | Maharashtra |
The incorporation date of CIPLA HEALTH LIMITED is 27 August, 2015
The authorized share capital of CIPLA HEALTH LIMITED is INR ₹ 10.0 Cr.
The paid-up capital of CIPLA HEALTH LIMITED is INR ₹ 2.3 Cr.
The registered address of CIPLA HEALTH LIMITED is FOFB-11, B Wing, Fourth Floor, Art Guild House Phoenix Marketcity, L.B.S Marg, Kurla (West) Mumbai Mumbai City Maharashtra - 400070
The CIN number of CIPLA HEALTH LIMITED is U24100MH2015PLC267880.
Expand
Delete
Collapse
See
details
